Chapter/Section Purchase

1 Introduction to Research & Analysis Reports
1.1 Drug Repositioning Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Drug Repositioning Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Drug Repositioning Overall Market Size
2.1 Global Drug Repositioning Market Size: 2021 VS 2028
2.2 Global Drug Repositioning Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Drug Repositioning Players in Global Market
3.2 Top Global Drug Repositioning Companies Ranked by Revenue
3.3 Global Drug Repositioning Revenue by Companies
3.4 Top 3 and Top 5 Drug Repositioning Companies in Global Market, by Revenue in 2021
3.5 Global Companies Drug Repositioning Product Type
3.6 Tier 1, Tier 2 and Tier 3 Drug Repositioning Players in Global Market
3.6.1 List of Global Tier 1 Drug Repositioning Companies
3.6.2 List of Global Tier 2 and Tier 3 Drug Repositioning Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Drug Repositioning Market Size Markets, 2021 & 2028
4.1.2 Oral
4.1.3 Intravenous
4.2 By Type - Global Drug Repositioning Revenue & Forecasts
4.2.1 By Type - Global Drug Repositioning Revenue, 2017-2022
4.2.2 By Type - Global Drug Repositioning Revenue, 2023-2028
4.2.3 By Type - Global Drug Repositioning Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Drug Repositioning Market Size, 2021 & 2028
5.1.2 Central Nervous Disorders
5.1.3 Cardiovascular Disorders
5.1.4 Oncology
5.1.5 Others
5.2 By Application - Global Drug Repositioning Revenue & Forecasts
5.2.1 By Application - Global Drug Repositioning Revenue, 2017-2022
5.2.2 By Application - Global Drug Repositioning Revenue, 2023-2028
5.2.3 By Application - Global Drug Repositioning Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Drug Repositioning Market Size, 2021 & 2028
6.2 By Region - Global Drug Repositioning Revenue & Forecasts
6.2.1 By Region - Global Drug Repositioning Revenue, 2017-2022
6.2.2 By Region - Global Drug Repositioning Revenue, 2023-2028
6.2.3 By Region - Global Drug Repositioning Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Drug Repositioning Revenue, 2017-2028
6.3.2 US Drug Repositioning Market Size, 2017-2028
6.3.3 Canada Drug Repositioning Market Size, 2017-2028
6.3.4 Mexico Drug Repositioning Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Drug Repositioning Revenue, 2017-2028
6.4.2 Germany Drug Repositioning Market Size, 2017-2028
6.4.3 France Drug Repositioning Market Size, 2017-2028
6.4.4 U.K. Drug Repositioning Market Size, 2017-2028
6.4.5 Italy Drug Repositioning Market Size, 2017-2028
6.4.6 Russia Drug Repositioning Market Size, 2017-2028
6.4.7 Nordic Countries Drug Repositioning Market Size, 2017-2028
6.4.8 Benelux Drug Repositioning Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Drug Repositioning Revenue, 2017-2028
6.5.2 China Drug Repositioning Market Size, 2017-2028
6.5.3 Japan Drug Repositioning Market Size, 2017-2028
6.5.4 South Korea Drug Repositioning Market Size, 2017-2028
6.5.5 Southeast Asia Drug Repositioning Market Size, 2017-2028
6.5.6 India Drug Repositioning Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Drug Repositioning Revenue, 2017-2028
6.6.2 Brazil Drug Repositioning Market Size, 2017-2028
6.6.3 Argentina Drug Repositioning Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Drug Repositioning Revenue, 2017-2028
6.7.2 Turkey Drug Repositioning Market Size, 2017-2028
6.7.3 Israel Drug Repositioning Market Size, 2017-2028
6.7.4 Saudi Arabia Drug Repositioning Market Size, 2017-2028
6.7.5 UAE Drug Repositioning Market Size, 2017-2028
7 Players Profiles
7.1 Novartis AG
7.1.1 Novartis AG Corporate Summary
7.1.2 Novartis AG Business Overview
7.1.3 Novartis AG Drug Repositioning Major Product Offerings
7.1.4 Novartis AG Drug Repositioning Revenue in Global Market (2017-2022)
7.1.5 Novartis AG Key News
7.2 Abbott Healthcare
7.2.1 Abbott Healthcare Corporate Summary
7.2.2 Abbott Healthcare Business Overview
7.2.3 Abbott Healthcare Drug Repositioning Major Product Offerings
7.2.4 Abbott Healthcare Drug Repositioning Revenue in Global Market (2017-2022)
7.2.5 Abbott Healthcare Key News
7.3 Pfizer
7.3.1 Pfizer Corporate Summary
7.3.2 Pfizer Business Overview
7.3.3 Pfizer Drug Repositioning Major Product Offerings
7.3.4 Pfizer Drug Repositioning Revenue in Global Market (2017-2022)
7.3.5 Pfizer Key News
7.4 Johnson & Johnson
7.4.1 Johnson & Johnson Corporate Summary
7.4.2 Johnson & Johnson Business Overview
7.4.3 Johnson & Johnson Drug Repositioning Major Product Offerings
7.4.4 Johnson & Johnson Drug Repositioning Revenue in Global Market (2017-2022)
7.4.5 Johnson & Johnson Key News
7.5 Hoffmann-La Roche
7.5.1 Hoffmann-La Roche Corporate Summary
7.5.2 Hoffmann-La Roche Business Overview
7.5.3 Hoffmann-La Roche Drug Repositioning Major Product Offerings
7.5.4 Hoffmann-La Roche Drug Repositioning Revenue in Global Market (2017-2022)
7.5.5 Hoffmann-La Roche Key News
7.6 Sandoz
7.6.1 Sandoz Corporate Summary
7.6.2 Sandoz Business Overview
7.6.3 Sandoz Drug Repositioning Major Product Offerings
7.6.4 Sandoz Drug Repositioning Revenue in Global Market (2017-2022)
7.6.5 Sandoz Key News
7.7 Mylan Inc.
7.7.1 Mylan Inc. Corporate Summary
7.7.2 Mylan Inc. Business Overview
7.7.3 Mylan Inc. Drug Repositioning Major Product Offerings
7.7.4 Mylan Inc. Drug Repositioning Revenue in Global Market (2017-2022)
7.7.5 Mylan Inc. Key News
7.8 Teva Pharmaceuticals
7.8.1 Teva Pharmaceuticals Corporate Summary
7.8.2 Teva Pharmaceuticals Business Overview
7.8.3 Teva Pharmaceuticals Drug Repositioning Major Product Offerings
7.8.4 Teva Pharmaceuticals Drug Repositioning Revenue in Global Market (2017-2022)
7.8.5 Teva Pharmaceuticals Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer